These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Assessing the social cost and benefits of a national requirement establishing antibiotic stewardship programs to prevent Scott RD; Slayton RB; Lessa FC; Baggs J; Culler SD; McDonald LC; Jernigan JA Antimicrob Resist Infect Control; 2019; 8():17. PubMed ID: 30680153 [TBL] [Abstract][Full Text] [Related]
4. Use of diagnostic and antimicrobial stewardship practices to improve Sullivan KV; Gallagher JC; Leekha S; Morgan DJ; Morita K; Rock C; Claeys KC Infect Control Hosp Epidemiol; 2022 Jul; 43(7):930-934. PubMed ID: 34376271 [TBL] [Abstract][Full Text] [Related]
5. Clostridioides difficile Infection in Children: The Role of Infection Prevention and Antimicrobial Stewardship. Savage TJ; Sandora TJ J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S64-S68. PubMed ID: 34791402 [TBL] [Abstract][Full Text] [Related]
6. Application of consolidated framework for implementation research to improve Clostridioides difficile infection management in district hospitals. Legenza L; Coetzee R; Rose WE; Esack T; Crombie K; Mina M; Safdar N; Barnett SG Res Social Adm Pharm; 2022 Dec; 18(12):4100-4111. PubMed ID: 35981939 [TBL] [Abstract][Full Text] [Related]
7. A review of epidemiological models of Clostridioides difficile transmission and control (2009-2021). Lanzas C; Jara M; Tucker R; Curtis S; Anaerobe; 2022 Apr; 74():102541. PubMed ID: 35217149 [TBL] [Abstract][Full Text] [Related]
8. Strategies to prevent adverse outcomes following Rauseo AM; Olsen MA; Reske KA; Dubberke ER Expert Rev Anti Infect Ther; 2020 Mar; 18(3):203-217. PubMed ID: 31976779 [No Abstract] [Full Text] [Related]
9. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic? Hawes AM; Desai A; Patel PK Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702 [TBL] [Abstract][Full Text] [Related]
10. Chasing the rate: An interrupted time series analysis of interventions targeting reported hospital onset Doll ME; Zhao J; Kang L; Rittmann B; Alvarez M; Fleming M; Cooper K; Stevens MP; Bearman G Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1142-1147. PubMed ID: 32493530 [TBL] [Abstract][Full Text] [Related]
11. Antibiotic Stewardship and Inpatient Clostridioides difficile Testing in Solid Organ Transplant Recipients: The Need for Multilevel Checks and Balances. Kueht M; Kharsa A; Mujtaba M; Kulkarni R; Britt R; Lea AS; Hafiz G; Fair J; Reynoso D Transplant Proc; 2022 Apr; 54(3):605-609. PubMed ID: 35249732 [TBL] [Abstract][Full Text] [Related]
12. How to: prophylactic interventions for prevention of Clostridioides difficile infection. Reigadas E; van Prehn J; Falcone M; Fitzpatrick F; Vehreschild MJGT; Kuijper EJ; Bouza E; Clin Microbiol Infect; 2021 Dec; 27(12):1777-1783. PubMed ID: 34245901 [TBL] [Abstract][Full Text] [Related]
13. The Effect of Clostridioides difficile Diagnostic Stewardship Interventions on the Diagnosis of Hospital-Onset Clostridioides difficile Infections. Kang M; Abeles SR; El-Kareh R; Taplitz RA; Nyheim E; Reed SL; Jenkins IH; Seymann GB; Myers FE; Torriani FJ; Jt Comm J Qual Patient Saf; 2020 Aug; 46(8):457-463. PubMed ID: 32576438 [TBL] [Abstract][Full Text] [Related]
14. Cutting edges in Clostridioides difficile infections. Durovic A; Tschudin-Sutter S Swiss Med Wkly; 2021 Sep; 151():w30033. PubMed ID: 34652093 [TBL] [Abstract][Full Text] [Related]
15. A cost of illness comparison for toxigenic Clostridioides difficile diagnosis algorithms in developing countries. Cançado GGL; Abreu ES; Nardelli MJ; Serwa P; Brachmann M Anaerobe; 2021 Aug; 70():102390. PubMed ID: 34058377 [TBL] [Abstract][Full Text] [Related]
16. Perils and pitfalls of probiotic quasi-experimental studies for primary prevention of Clostridioides difficile infection: A review of the evidence. McFarland LV; Johnson SB; Evans CT Am J Infect Control; 2021 Mar; 49(3):375-384. PubMed ID: 32791261 [TBL] [Abstract][Full Text] [Related]
17. Prevention of Clostridioides difficile in hospitals: A position paper of the International Society for Infectious Diseases. Doll M; Marra AR; Apisarnthanarak A; Al-Maani AS; Abbas S; Rosenthal VD Int J Infect Dis; 2021 Jan; 102():188-195. PubMed ID: 33122100 [TBL] [Abstract][Full Text] [Related]
18. Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: 12-Month Observational Data From the Randomized Phase III Trial, MODIFY II. Goldstein EJC; Citron DM; Gerding DN; Wilcox MH; Gabryelski L; Pedley A; Zeng Z; Dorr MB Clin Infect Dis; 2020 Aug; 71(4):1102-1105. PubMed ID: 31883370 [TBL] [Abstract][Full Text] [Related]
19. Prevention of Infection due to Clostridium (Clostridioides) difficile. Krishna A; Chopra T Infect Dis Clin North Am; 2021 Dec; 35(4):995-1011. PubMed ID: 34752229 [TBL] [Abstract][Full Text] [Related]